Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-10

This study found elevated serum levels of SIL-2R, IL-6, and IL-1a in women with endometriosis compared to controls, with danazol treatment significantly reducing these markers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

This study examined whether danazol alters cell-mediated immunity by measuring serum soluble interleukin-2 receptor (SIL-2R), interleukin-6 (IL-6), and interleukin-1 alpha (IL-1a) in 10 infertile women with endometriosis and 10 normal controls, with additional longitudinal sampling in the endometriosis group before treatment, during the last 15 days of a 6-month danazol course, and three months after stopping. The authors found higher SIL-2R, IL-6, and IL-1a levels in women with endometriosis before treatment compared with controls, and danazol significantly reduced all three interleukins during therapy. The paper’s main limitation is that only one blood sample was taken from each of the 10 controls, reducing ability to assess temporal changes in the control group. This paper is centrally about endometriosis — it measures immune cytokines (SIL-2R, IL-6, IL-1a) and reports danazol-associated reductions in endometriosis-related immune abnormalities.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The aim of this study was to verify to what extent danazol alters cell-mediated immunity. To this end, cell-mediated immunity was studied in 10 infertile patients with endometriosis and in 10 normal controls. Nonspecific parameters studied included serum SIL-2R, IL-6 and IL-1a levels. We also investigated the effect of treatment with Danazol on the levels of SIL-2R, IL-6 and IL-1a in women with endometriosis. Blood SIL-2R, IL-6 and IL-1a levels were measured in endometriotic women before treatment, during the last fifteen days of a 6-months course of Danazol and three months after treatment. Only one blood sample was taken from 10 women without endometriosis. SIL-2R, IL-6 and IL-1a levels were higher in women with endometriosis before treatment compared with controls. Administration of the drug significantly reduced the levels of SIL-2R (P < 0.001), IL-6 (P < 0.05) and IL-1a (P < 0.01). Our findings suggest that endometriosis is a condition which induces a rise in interleukin levels. Danazol also appears significantly to reduce endometriosis-associated autoimmune abnormalities.
Full text 4,660 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

The aim of this study was to verify to what extent danazol alters cell-mediated immunity. To this end, cell-mediated immunity was studied in 10 infertile patients with endometriosis and in 10 normal controls. Nonspecific parameters studied included serum SIL-2R, IL-6 and IL-1a levels. We also investigated the effect of treatment with Danazol on the levels of SIL-2R, IL-6 and IL-1a in women with endometriosis. Blood SIL-2R, IL-6 and IL-1a levels were measured in endometriotic women before treatment, during the last fifteen days of a 6-months course of Danazol and three months after treatment. Only one blood sample was taken from 10 women without endometriosis. SIL-2R, IL-6 and IL-1a levels were higher in women with endometriosis before treatment compared with controls. Administration of the drug significantly reduced the levels of SIL-2R (P<0.001), IL-6 (P<0.05) and IL-1a (P<0.01). Our findings suggest that endometriosis is a condition which induces a rise in interleukin levels. Danazol also appears significantly to reduce endometriosis — associated autoimmune abnormalities. Similar content being viewed by others

References

American Fertility Society (1985) Revised American Fertility Society, Classification of Endometriosis. Fertil Steril 43:351–356 Badawy SZ, Cuenca V, Stitzel A et al (1984) Autoimmune phenomena in infertile patients with endometriosis. Obstet Gynecol 63:271–275 Badawy SZ, Cuenca V, Kaufman L, et al (1989) The regulation of immunoglobulins peoduction by B cells in patients with endometriosis. Fertil Steril 51:770–773 Bayshave KD (1985) Cancer drug targeting. Clin Radiol 36:545–549 Buttram VC, Reiter RC, Ward S (1985) Treatment of endometriosis with Danazol: Report of a 6-year prospective study. Fertil Steril 43:353–360 Cimino G, Avvisati G, Amadori S, et al (1982) High serum interleukin-2 levels in patients with monoclonal gammopathy of underermined significance (MGUS) and multiple myeloma. Nouv Rev Fr Hematol 41:329–332 Dinarello CA (1985) An update on human interleukin-1: from molecular biology to clinical relevance. J Clin Immunol 5:287–290 Dmowski WP, Radwanska E (1984) Endometriosis and infertility. Acta Obstet Gynecol Scand (Suppl) 123:73–75 Dmowski WP, Steel RW, Baker GF (1981) Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 141:377–381 Fakin H, Baggett B, Holtz G, et al. (1987) Interleukin 1: a possible role in the infertility associated with endometriosis. Fertil Steril 47:213–217 Falkoff RJ, Muraguchi A, Hong JX, et al (1983) The effects of inerleukin-1 on human B-cell activation and proliferation. J Immunol 131:801–805 Gleicher N, EI-Roeiy A, Confino E, et al (1987) Autoantibodies in reproductive failure: I. Is endometriosis and autoimmune disease. Obstet Gynecol 70:115–119 Grossman CJ (1985) Interactions between the gonadal steroids and the immune system. Science 227:257–261 Haney AF, Muscato JJ, Weinberg JB (1981) Peritoneal fluid cell population in infertility patients. Fertil Steril 35:696–699 Haney AF, Misukonis MA, Weinberg JB (1983) Macrophages and infertility. Oviductal macrophages as potential mediators of infertility. Fertil Steril 39:310–315 Kishimoto T, Hirano T (1988) Molecular regulation of the B lymphocyte response. Ann Rev Immunol 6:485–489 Mizel B (1982) Interleukin-1 and T-cell activation. Immunol Rev 63:51–55 Osawa H, Josimovic-Alesevic O, Diamantstein T (1986) Interleukin 2 receptors are released by cells in vitro and in vivo. Eur Immunol 16:467–469 Rossi V, Breviario F, Ghezzi P (1985) Interleukin-1 induces prostacylin in vascular cells. Science 229:174–177 Steele RW, Dmowski WP, Marmer DJ (1984) Immunologic aspects of human endometriosis. Am J Reprod Immunol 6:33–36 Sthoeger ZM, Chiorazz N, Lahita G (1981) Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation. J Immunol 141:91–95 Suginami H, Yano K, Watanabe K (1986) A factor inhibiting ovum capture by the oviductal fimbrial present in endometriosis peritoneal fluid. Fertil Steril 46:1140–1146 Weed JC, Arguembourg PC (1989) Endometriosis. Can it produce an autoimmune response resulting infertility. Clin Obstet Gynecol 23:885–889 Author information Authors and Affiliations Rights and permissions About this article Cite this article Koumantakis, E., Matalliotakis, I., Neonaki, M. et al. Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls. Arch Gynecol Obstet 255, 107–112 (1994). https://doi.org/10.1007/BF02390936 Received: Accepted: Issue date: DOI: https://doi.org/10.1007/BF02390936

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Danazol Endometriosis Interleukin-1 Interleukin-6 Receptors, Interleukin-2 Adult Autoimmune Diseases Autoimmune Diseases Autoimmune Diseases Danazol Danazol Endometriosis Endometriosis Female Humans Immunity, Cellular Immunity, Cellular Immunity, Cellular Infertility, Female Infertility, Female

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
pubmed
last seen: 2026-05-13T22:11:34.315996+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine